[An open and controlled study of effectiveness and tolerance of Livostin eyedrops].
The authors present the result of an open controlled trial of the effectiveness of a new antiallergic ophthalmological preparation, Livostin, for local use, a product of Janssen-CILAG. They evaluate the results obtained in 86 patients with symptoms of allergic conjunctivitis. The preparation was followed up for four weeks, in particular the rate of onset of effect and its duration. Evidence was provided that this preparation is a highly effective local antiallergic drug with a long-term effect.
Stara
J
J
I. Ocní Klinika 1. LF UK, Praha.
Krásný
J
J
Plísková
S
S
Síblová
O
O
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D003233:Conjunctivitis, Allergic / Q000188:drug therapy*; D005260:Female; D006634:Histamine H1 Antagonists / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009883:Ophthalmic Solutions; D010880:Piperidines / Q000008:administration & dosage* / Q000627:therapeutic use
D006634:Histamine H1 Antagonists; D009883:Ophthalmic Solutions; D010880:Piperidines; C047340:levocabastine